Ruud P.M. Dings Source Confirmed

OverviewAI-generated summary

Ruud P.M. Dings leads a research group at the University of Arkansas at Fayetteville, focusing on the interplay between cellular processes, the immune system, and therapeutic interventions. His work investigates mechanisms of tumor cell behavior, including dormancy induced by agents like CB-839 and the role of tumor endothelial cell anergy in response to VEGF-targeted treatments. Dings also explores synergistic activities in cellular networks, as demonstrated by his simulations of galectin networks. His research extends to the application of nanotechnology, specifically gold nanostructures, for photothermal action and the enhancement of immune cell function, including the targeting of regulatory T cells.

Dings' publications also address the impact of dysbiosis on tumor vasculature sensitivity to radiotherapy and c-Met inhibitors, and the biocompatibility of materials like ether-based urethane films for dendritic cells. He has a significant scholarly output, with 123 publications and over 5,124 citations, resulting in an h-index of 39. He is recognized as a highly cited researcher. Key collaborators include Samir V. Jenkins and Narasimhan Rajaram from the University of Arkansas for Medical Sciences and University of Arkansas at Fayetteville, respectively, with whom he has co-authored multiple publications.

Metrics

• h-index: 39
• Publications: 123
• Citations: 5,124